Mesenchymal Stem Cell-Derived Extracellular Vesicles Decrease Lung Injury in Mice

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Human mesenchymal stem cell (MSC) extracellular vesicles (EVs) show potential in reducing bacterial pneumonia severity.
• The precise mechanisms of MSC EV antimicrobial activity remain largely unknown.

Purpose of the Study:

• To elucidate the mechanisms by which MSC EVs exert antimicrobial effects in bacterial pneumonia.
• To investigate the role of leukotriene (LT) metabolism in MSC EV-mediated bacterial clearance.

Main Methods:

• Investigated bacterial clearance in *Escherichia coli* pneumonia mouse models treated with MSC EVs.
• Assessed leukotriene B4 (LTB4) levels and the impact of LTB4/BLT1 antagonists.
• Examined the effect of MSC EVs on multidrug resistance-associated protein 1 (MRP1) expression and function in vitro.
• Utilized miR-145 knockdown to determine its role in MSC EV-mediated effects.

Main Results:

• MSC EV treatment led to increased LTB4 levels in lung alveoli and enhanced bacterial clearance.
• Antimicrobial effects of MSC EVs were blocked by a LTB4 BLT1 antagonist.
• MSC EVs suppressed MRP1 mRNA, protein, and pump function, increasing LTB4 production.
• miR-145 transfer from MSC EVs was identified as the mechanism for MRP1 inhibition and subsequent antimicrobial activity.

Conclusions:

• MSC EVs enhance antimicrobial activity against bacterial pneumonia by suppressing MRP1 via miR-145 transfer.
• This suppression increases LTB4 production, which then activates LTB4/BLT1 signaling to clear bacteria.